BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34922264)

  • 21. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
    Hu J; Jiao X; Zhu L; Guo H; Wu Y
    BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.
    Nassir M; Guan J; Luketina H; Siepmann T; Rohr I; Richter R; Castillo-Tong DC; Zeillinger R; Vergote I; Van Nieuwenhuysen E; Concin N; Marth C; Hall C; Mahner S; Woelber L; Sehouli J; Braicu EI
    Tumour Biol; 2016 Mar; 37(3):3009-16. PubMed ID: 26419591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
    Hess J; Unger K; Maihoefer C; Schüttrumpf L; Wintergerst L; Heider T; Weber P; Marschner S; Braselmann H; Samaga D; Kuger S; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Werner K; Baumann M; Budach V; Combs SE; Debus J; Grosu AL; Krause M; Linge A; Rödel C; Stuschke M; Zips D; Zitzelsberger H; Ganswindt U; Henke M; Belka C
    Clin Cancer Res; 2019 Mar; 25(5):1505-1516. PubMed ID: 30171046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.
    Chung HH; Kim JW; Park NH; Song YS; Cheon GJ
    Eur Radiol; 2018 May; 28(5):2107-2114. PubMed ID: 29260365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z; Zhu X; Teng Y
    Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 28. Exploring the prognostic significance of preoperative high normocalcemia in epithelial ovarian carcinoma.
    Cho HW; Ouh YT; Hong JH; Lee JK
    Arch Gynecol Obstet; 2021 Mar; 303(3):803-810. PubMed ID: 33078229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods.
    Paik ES; Lee JW; Park JY; Kim JH; Kim M; Kim TJ; Choi CH; Kim BG; Bae DS; Seo SW
    J Gynecol Oncol; 2019 Jul; 30(4):e65. PubMed ID: 31074247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
    Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
    Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.
    Ditto A; Leone Roberti Maggiore U; Bogani G; Martinelli F; Chiappa V; Evangelista MT; Liberale V; Ferrero S; Raspagliesi F
    Int J Gynaecol Obstet; 2019 Apr; 145(1):28-33. PubMed ID: 30698271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.
    Paik ES; Sohn I; Baek SY; Shim M; Choi HJ; Kim TJ; Choi CH; Lee JW; Kim BG; Lee YY; Bae DS
    Cancer Res Treat; 2017 Jul; 49(3):635-642. PubMed ID: 27669704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
    J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study.
    Nie D; Gong H; Mao X; Li Z
    Gynecol Oncol; 2019 Feb; 152(2):259-264. PubMed ID: 30558974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
    Liu J; Xu W; Li S; Sun R; Cheng W
    Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer.
    Wei W; Li N; Sun Y; Li B; Xu L; Wu L
    Oncotarget; 2017 Apr; 8(14):23862-23870. PubMed ID: 27852043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.
    Liu M; Mor G; Cheng H; Xiang X; Hui P; Rutherford T; Yin G; Rimm DL; Holmberg J; Alvero A; Silasi DA
    Reprod Sci; 2013 May; 20(5):605-15. PubMed ID: 23171677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.